{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T16:31:40Z","timestamp":1791304300832,"version":"4.3.1"},"reference-count":49,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2019,7,17]],"date-time":"2019-07-17T00:00:00Z","timestamp":1563321600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["European J of Haematology"],"published-print":{"date-parts":[[2019,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Objective<\/jats:title><jats:p>Clozapine is the favoured antipsychotic for treatment\u2010refractory schizophrenia, but has a 1%\u20102% incidence of agranulocytosis. Patients who require chemotherapy therefore pose a unique management dilemma for haematologists, oncologists and psychiatrists.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>The Ovid MEDLINE and EMBASE databases were searched to identify reports describing use of clozapine concurrent with chemotherapy until 31 March 2019. The following terms (with variations) were used: neoplasm, cancer, tumour, malignancy, chemotherapy, antineoplastic and clozapine.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Twenty\u2010seven cases were included after reviewing titles and abstracts for relevance. Fifteen patients had solid organ tumours, and 12 had haematological malignancies, including three who underwent autologous haematopoietic stem cell transplantation (AutoHSCT). Clozapine was continued in 14 cases (albeit dose reduced in 2), with a reported median neutropaenic nadir of 0.29\u00a0\u00d7\u00a010<jats:sup>9<\/jats:sup>\/L (range 2.2 to &lt;0.0\u00a0\u00d7\u00a010<jats:sup>9<\/jats:sup>\/L). Clozapine was discontinued or substituted for another antipsychotic in the remaining 13 cases, all except one of whom experienced marked psychiatric deterioration. The only neutropenia\u2010related complication was one case of bacteraemia with high\u2010dose melphalan conditioning for AutoHSCT.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>These findings argue in favour of clozapine continuation during chemotherapy. Further research is needed to develop guidance to minimise the risk of neutropenia\u2010related complications from concurrent treatment.<\/jats:p><\/jats:sec>","DOI":"10.1111\/ejh.13285","type":"journal-article","created":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T07:29:08Z","timestamp":1561966148000},"page":"277-286","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Feasibility of myelosuppressive chemotherapy in psychiatric patients on clozapine: A systematic review of the literature"],"prefix":"10.1111","volume":"103","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1067-9315","authenticated-orcid":false,"given":"Brian T.","family":"Grainger","sequence":"first","affiliation":[{"name":"Department of Haematology Auckland City Hospital Auckland New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murat O.","family":"Arcasoy","sequence":"additional","affiliation":[{"name":"Division of Hematology Duke University Medical Center Durham NC USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher A.","family":"Kenedi","sequence":"additional","affiliation":[{"name":"Departments of General Medicine and Liaison Psychiatry Auckland City Hospital Auckland New Zealand"},{"name":"Divisions of Internal Medicine and Psychiatry Duke University Medical Center Durham NC USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2019,7,17]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1993.01820140007001"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.158.4.518"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1093\/epirev\/mxn001"},{"key":"e_1_2_6_5_1","first-page":"47","article-title":"Suicide and schizophrenia: clozapine and the InterSePT study. International Clozaril\/Leponex Suicide Prevention Trial","volume":"60","author":"Meltzer HY","year":"1999","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1K662"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v64n0416"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.genhosppsych.2017.02.004"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2014.07.103"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2017.12.102"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01064682"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.encep.2013.02.003"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-016-0311-1"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199307153290303"},{"key":"e_1_2_6_15_1","volume-title":"Clozaril (Clozapine) Prescribing Information, in Novartis Pharmaceuticals","author":"Novartis Pharmaceuticals","year":"2010"},{"key":"e_1_2_6_16_1","volume-title":"Summary of Product Characteristics \u2013 Leponex","author":"The European Agency for the Evaluation of Medicinal Products","year":"2002"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2009.06.005"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1177\/0004867414539399"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.150.10.1562"},{"key":"e_1_2_6_20_1","first-page":"59","article-title":"Clozapine and full\u2010dose concomitant chemoradiation therapy in a schizophrenic patient with nasopharyngeal cancer","volume":"88","author":"Bareggi C","year":"2002","journal-title":"Tumori"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1002\/pon.3779"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1002\/pnp.434"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.psym.2015.02.005"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2007.12.006"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.psym.2014.05.007"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.4103\/0019-5545.130507"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2008.05.017"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1002\/pon.1267"},{"issue":"3","key":"e_1_2_6_29_1","first-page":"237","article-title":"Clozapine and chemotherapy","volume":"7","author":"Haut F","year":"1995","journal-title":"J Drug Dev Clin Pract"},{"issue":"4","key":"e_1_2_6_30_1","first-page":"845","article-title":"Adjuvant chemotherapy for breast cancer in patients with schizophrenia","volume":"3","author":"Hwang M","year":"2012","journal-title":"Oncol Lett"},{"key":"e_1_2_6_31_1","doi-asserted-by":"publisher","DOI":"10.1002\/pon.3209"},{"key":"e_1_2_6_32_1","doi-asserted-by":"publisher","DOI":"10.1176\/jnp.2010.22.4.451.e4"},{"key":"e_1_2_6_33_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ps.52.1.110"},{"issue":"8","key":"e_1_2_6_34_1","first-page":"831","article-title":"Clozapine and chemotherapy","volume":"45","author":"McKenna RC","year":"1994","journal-title":"Hosp Community Psychiatry"},{"key":"e_1_2_6_35_1","doi-asserted-by":"publisher","DOI":"10.1002\/pon.3744"},{"key":"e_1_2_6_36_1","doi-asserted-by":"publisher","DOI":"10.2147\/NDT.S49028"},{"key":"e_1_2_6_37_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11096-016-0268-7"},{"key":"e_1_2_6_38_1","doi-asserted-by":"publisher","DOI":"10.4103\/0019-5545.196711"},{"issue":"6","key":"e_1_2_6_39_1","first-page":"42","article-title":"Managing schizophrenia in a patient with cancer: a fine balance","volume":"16","author":"Riddle M","year":"2017","journal-title":"Curr Psychiatry"},{"key":"e_1_2_6_40_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2007.06122021"},{"issue":"4","key":"e_1_2_6_41_1","first-page":"419","article-title":"Clozapine, cancer chemotherapy and neutropenia \u2013 dilemmas in management","volume":"25","author":"Sankaranarayanan A","year":"2013","journal-title":"Psychiatr Danub"},{"key":"e_1_2_6_42_1","doi-asserted-by":"publisher","DOI":"10.1177\/2045125314553610"},{"issue":"10","key":"e_1_2_6_43_1","first-page":"673","article-title":"Chemotherapy during clozapine treatment. Increased risk of agranulocytosis (Original: Chemotherapie bij gebruik van clozapine; een vergoogde kans op agranulocytose?)","volume":"50","author":"Gool A","year":"2008","journal-title":"Tijdschrift voor Psychiatrie"},{"key":"e_1_2_6_44_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.161.1.175"},{"key":"e_1_2_6_45_1","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0000000000000970"},{"key":"e_1_2_6_46_1","doi-asserted-by":"publisher","DOI":"10.1192\/pb.bp.114.048306"},{"key":"e_1_2_6_47_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.178.6.576-a"},{"key":"e_1_2_6_48_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.168.2.217"},{"key":"e_1_2_6_49_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.62.3488"},{"key":"e_1_2_6_50_1","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0000000000000715"}],"container-title":["European Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fejh.13285","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ejh.13285","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/ejh.13285","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ejh.13285","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T06:06:22Z","timestamp":1693548382000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/ejh.13285"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,17]]},"references-count":49,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["10.1111\/ejh.13285"],"URL":"https:\/\/doi.org\/10.1111\/ejh.13285","archive":["Portico"],"relation":{},"ISSN":["0902-4441","1600-0609"],"issn-type":[{"value":"0902-4441","type":"print"},{"value":"1600-0609","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,17]]},"assertion":[{"value":"2019-05-06","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-06-24","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-07-17","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}